ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Dicyclohexylcarbodiimide → t-Butyldimethylsilyl 6-O-{3-O-allyloxycarbonyl-6-O-benzyl-2-deoxy-4-O-(1,5-dihydro-3-oxo-3lambda5-3H-2,4,3-benzodioxaphosphepin-3yl)-2-[(R)-3-dodecanoyloxy-tetradecanoylamino]-beta-D-glucopyranosyl}-2-azido-4-O-benzyl-3-O-[(R)-3-benzyloxy-tetradecanoyl]-2-deoxy-beta-D-glucopyranoside

HRID 628193
ノート
印刷プレビュー

反応式

HRID 628193 の反応式
[CH2:1]([O:8][C@H:9]([CH2:14][CH2:15][CH2:16][CH2:17][CH2:18][CH2:19][CH2:20][CH2:21][CH2:22][CH2:23][CH3:24])[CH2:10][C:11]([OH:13])=[O:12])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.C1CCC(N=C=NC2CCCCC2)CC1.[CH2:40]([O:43][C:44]([O:46][C@H:47]1[C@H:52]([O:53][P:54]2(=[O:65])[O:60][CH2:59][C:58]3[CH:61]=[CH:62][CH:63]=[CH:64][C:57]=3[CH2:56][O:55]2)[C@@H:51]([CH2:66][O:67][CH2:68][C:69]2[CH:74]=[CH:73][CH:72]=[CH:71][CH:70]=2)[O:50][C@@H:49]([O:75][CH2:76][C@H:77]2[O:90][C@@H:81]([O:82][Si:83]([C:86]([CH3:89])([CH3:88])[CH3:87])([CH3:85])[CH3:84])[C@H:80]([N:91]=[N+:92]=[N-:93])[C@@H:79](O)[C@@H:78]2[O:95][CH2:96][C:97]2[CH:102]=[CH:101][CH:100]=[CH:99][CH:98]=2)[C@@H:48]1[NH:103][C:104](=[O:132])[CH2:105][C@H:106]([O:118][C:119](=[O:131])[CH2:120][CH2:121][CH2:122][CH2:123][CH2:124][CH2:125][CH2:126][CH2:127][CH2:128][CH2:129][CH3:130])[CH2:107][CH2:108][CH2:109][CH2:110][CH2:111][CH2:112][CH2:113][CH2:114][CH2:115][CH2:116][CH3:117])=[O:45])[CH:41]=[CH2:42]>C(Cl)Cl.CN(C1C=CN=CC=1)C>[CH2:40]([O:43][C:44]([O:46][C@H:47]1[C@H:52]([O:53][P:54]2(=[O:65])[O:60][CH2:59][C:58]3[CH:61]=[CH:62][CH:63]=[CH:64][C:57]=3[CH2:56][O:55]2)[C@@H:51]([CH2:66][O:67][CH2:68][C:69]2[CH:70]=[CH:71][CH:72]=[CH:73][CH:74]=2)[O:50][C@@H:49]([O:75][CH2:76][C@H:77]2[O:90][C@@H:81]([O:82][Si:83]([C:86]([CH3:87])([CH3:89])[CH3:88])([CH3:84])[CH3:85])[C@H:80]([N:91]=[N+:92]=[N-:93])[C@@H:79]([O:12][C:11](=[O:13])[CH2:10][C@H:9]([O:8][CH2:1][C:2]3[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=3)[CH2:14][CH2:15][CH2:16][CH2:17][CH2:18][CH2:19][CH2:20][CH2:21][CH2:22][CH2:23][CH3:24])[C@@H:78]2[O:95][CH2:96][C:97]2[CH:98]=[CH:99][CH:100]=[CH:101][CH:102]=2)[C@@H:48]1[NH:103][C:104](=[O:132])[CH2:105][C@H:106]([O:118][C:119](=[O:131])[CH2:120][CH2:121][CH2:122][CH2:123][CH2:124][CH2:125][CH2:126][CH2:127][CH2:128][CH2:129][CH3:130])[CH2:107][CH2:108][CH2:109][CH2:110][CH2:111][CH2:112][CH2:113][CH2:114][CH2:115][CH2:116][CH3:117])=[O:45])[CH:41]=[CH2:42]
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 3

HCID 10868DicyclohexylcarbodiimideHCID 11110428(R)-3-(Benzyloxy)tetradecanoic acidHCID 16216230t-Butyldimethylsilyl 6-O-{3-O-allyloxycarbonyl-6-O-benzyl-2-deoxy-4-O-(1,5-dihydro-3-oxo-3lambda5-3H-2,4,3-benzodioxaphosphepin-3yl)-2-[(R)-3-dodecanoyloxy-tetradecanoylamino]-beta-D-glucopyranosyl}-2-azido-4-O-benzyl-2-deoxy-beta-D-glucopyranoside

生成物 1

HCID 16216359
t-Butyldimethylsilyl 6-O-{3-O-allyloxycarbonyl-6-O-benzyl-2-deoxy-4-O-(1,5-dihydro-3-oxo-3lambda5-3H-2,4,3-benzodioxaphosphepin-3yl)-2-[(R)-3-dodecanoyloxy-tetradecanoylamino]-beta-D-glucopyranosyl}-2-azido-4-O-benzyl-3-O-[(R)-3-benzyloxy-tetradecanoyl]-2-deoxy-beta-D-glucopyranoside
収率 86%

試薬・触媒・溶媒 2

HCID 142844-(Dimethylamino)pyridine触媒HCID 6344Dichloromethane溶媒2 回

実験手順

A reaction mixture of (R)-3-benzyloxy-tetradecanoic acid 15 (100 mg, 0.293 mmol) and DCC (93 mg, 0.450 mmol) in DCM (5 mL) was stirred at room temperature for 10 min, and then disaccharide 21 (300 mg, 0.225 mmol) in DCM (3 mL) and DMAP (11 mg, 0.090 mmol) were added. The reaction mixture was stirred at room temperature for 14 h, after which the solids were removed by filtration, and the residue washed with DCM (2×1 mL). The combined filtrates were concentrated in vacuo, and the residue was purified by silica gel column chromatography (hexane/ethyl acetate, 4/1, v/v) to give 22 as a white solid (319 mg, 86%). Rf=0.41 (hexane/ethyl acetate, 2/1, v/v). [α]26D=−2.8° (c=1.0, CHCl3). 1H NMR (500 MHz, CDCl3): δ 7.33-7.15 (m, 19H, aromatic), 5.94-5.85 (m, 2H, NH, OCH2CH═CH2), 5.45 (t, 1H, J2′,3′=J3′,4′=9.5 Hz, H-3′), 5.34 (d, 1H, J=17.5 Hz, OCH2CH═CH2), 5.22 (d, 1H, J=10.0 Hz, OCH2CH═CH2), 5.08-4.95 (m, 7H, H-1, H-3, H-3L, C6H4(CH2O)2P), 4.61-4.44 (m, 10H, H-1, H-4′, 3×CH2Ph, OCH2CH═CH2), 3.96 (d, 1H, J6′a,6′b=10.5 Hz, H-6′a), 3.88-3.85 (m, 1H, H-3S), 3.80 (d, 1H, J6a,6b=9.5 Hz, H-6a), 3.72-3.66 (m, 3H, H-5′, H-6b, H-6′b), 3.55-3.52 (m, 2H, H-4, H-5), 3.47-3.41 (m, 1H, H-2′), 3.27 (dd, 1H, J1,2=7.5 Hz, J2,3=10.0 Hz, H-2), 2.56 (dd, 1H, J2Sa,2Sb=16.0 Hz, J2Sa,3S=7.0 Hz, H-2Sa), 2.43 (dd, 1H, J2Sa,2Sb=16.0 Hz, J2Sb,3S=7.0 Hz, H-2Sb), 2.35 (dd, 1H, J2La,2Lb=15.0 Hz, J2La,3L=6.0 Hz, H-2La), 2.30-2.20 (m, 3H, H-2L′, H-2L′b), 1.59-1.52 (m, 6H, H-4L, H-4S, H-3L′), 1.23 (broad, 52H, 26×CH2, lipid), 0.90 (s, 9H, SiC(CH3)3), 0.88-0.84 (m, 9H, 3×CH3, lipid), 0.12 (s, 6H, Si(CH3)2). 13C NMR (75 MHz, CDCl3): δ 173.40 (C═O), 170.55 (C═O), 169.94 (C═O), 154.42 (C═O), 138.46-127.35 (aromatic, OCH2CH═CH2), 118.74 (OCH2CH═CH2), 99.29 (C-1′), 96.96 (C-1), 75.89, 75.62, 74.75, 74.28, 74.02, 73.67, 73.41, 71.34, 70.89, 68.87-67.85 (m), 66.48, −4.18 (Si(CH3)2), −5.38 (Si(CH3)2). HR MS (m/z) calculated for C91H139N4O19Psi[M+Na]+, 1673.9438. found, 1674.1754.

後処理

  1. stirringThe reaction mixture was stirred at room temperature for 14 h
  2. customafter which the solids were removed by filtration
  3. washthe residue washed with DCM (2×1 mL)
  4. concentrationThe combined filtrates were concentrated in vacuo
  5. customthe residue was purified by silica gel column chromatography (hexane/ethyl acetate, 4/1

出典と根拠

ORDレコード
ord-9aa614a2fc164cefaa96d247f5fd6841
出典データセット
uspto-grants-2016_04
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US09309276B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート